Literature DB >> 21898497

Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking.

Chuanghong Wu1, Richard Gilroy, Ryan Taylor, Mojtaba Olyaee, Bashar Abdulkarim, Jameson Forster, Maura O'Neil, Ivan Damjanov, Yu-Jui Yvonne Wan.   

Abstract

UNLABELLED: The current study tests a hypothesis that nuclear receptor signaling is altered in chronic hepatitis C patients and that the altered pattern is specific to alcohol drinking history. The expression of a panel of more than 100 genes encoding nuclear receptors, coregulators, and their direct/indirect targets was studied in human livers. Gene expression pattern was compared between 15 normal donor livers and 23 hepatitis C virus (HCV) genotype 1-positive livers from patients without a drinking history (matched for age, sex, and body mass index). HCV infection increased the expression of nuclear receptors small heterodimer partner and constitutive androstane receptor (CAR) as well as genes involved in fatty acid trafficking, bile acid synthesis and uptake, and inflammatory response. However, the expression of retinoid X receptor (RXR) α, peroxisomal proliferator-activated receptor (PPAR) α and β as well as steroid regulatory element-binding protein (SREBP)-1c was decreased in HCV-infected livers. Gene expression pattern was compared in chronic hepatitis C patients with and without a drinking history. Alcohol drinking increased the expression of genes involved in fatty acid uptake, trafficking, and oxidation, but decreased the expression of genes responsible for gluconeogenesis. These changes were consistent with reduced fasting plasma glucose levels and altered expression of upstream regulators that include RXRα, PPARα, and CAR. The messenger RNA levels of fibroblast growth factor 21, interleukin-10, and fatty acid synthase, which are all regulated by nuclear receptors, showed independent correlation with hepatic HCV RNA levels.
CONCLUSION: Our findings suggest that those genes and pathways that showed altered expression could potentially be therapeutic targets for HCV infection and/or alcohol drinking-induced liver injury.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21898497      PMCID: PMC3230737          DOI: 10.1002/hep.24645

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  55 in total

1.  Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.

Authors:  Li Ye; Shihong Wang; Xu Wang; Yu Zhou; Jieliang Li; Yuri Persidsky; Wenzhe Ho
Journal:  Drug Alcohol Depend       Date:  2010-06-20       Impact factor: 4.492

2.  Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.

Authors:  N Fujita; M Kaito; M Kai; R Sugimoto; H Tanaka; S Horiike; M Konishi; M Iwasa; S Watanabe; Y Adachi
Journal:  J Viral Hepat       Date:  2006-07       Impact factor: 3.728

Review 3.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

4.  Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis.

Authors:  Silvia Mirandola; Stefano Realdon; Jahangir Iqbal; Martina Gerotto; Francesca Dal Pero; Gladis Bortoletto; Moira Marcolongo; Alessandro Vario; Christian Datz; M Mahmood Hussain; Alfredo Alberti
Journal:  Gastroenterology       Date:  2006-03-06       Impact factor: 22.682

5.  Host- and disease-specific factors affecting steatosis in chronic hepatitis C.

Authors:  A J Czaja; H A Carpenter; P J Santrach; S B Moore
Journal:  J Hepatol       Date:  1998-08       Impact factor: 25.083

6.  Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.

Authors:  Yuki Nishimura-Sakurai; Naoya Sakamoto; Kaoru Mogushi; Satoshi Nagaie; Mina Nakagawa; Yasuhiro Itsui; Megumi Tasaka-Fujita; Yuko Onuki-Karakama; Goki Suda; Kako Mishima; Machi Yamamoto; Mayumi Ueyama; Yusuke Funaoka; Takako Watanabe; Seishin Azuma; Yuko Sekine-Osajima; Sei Kakinuma; Kiichiro Tsuchiya; Nobuyuki Enomoto; Hiroshi Tanaka; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2009-12-12       Impact factor: 7.527

7.  Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome.

Authors:  Toshiya Tanaka; Joji Yamamoto; Satoshi Iwasaki; Hiroshi Asaba; Hiroki Hamura; Yukio Ikeda; Mitsuhiro Watanabe; Kenta Magoori; Ryoichi X Ioka; Keisuke Tachibana; Yuichiro Watanabe; Yasutoshi Uchiyama; Koichi Sumi; Haruhisa Iguchi; Sadayoshi Ito; Takefumi Doi; Takao Hamakubo; Makoto Naito; Johan Auwerx; Masashi Yanagisawa; Tatsuhiko Kodama; Juro Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-15       Impact factor: 11.205

8.  Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.

Authors:  John G McHutchison; Gregory T Everson; Stuart C Gordon; Ira M Jacobson; Mark Sulkowski; Robert Kauffman; Lindsay McNair; John Alam; Andrew J Muir
Journal:  N Engl J Med       Date:  2009-04-30       Impact factor: 91.245

9.  Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production.

Authors:  Wei Yang; Brian L Hood; Sara L Chadwick; Shufeng Liu; Simon C Watkins; Guangxiang Luo; Thomas P Conrads; Tianyi Wang
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

10.  Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma.

Authors:  Kyeongjin Kim; Kook Hwan Kim; Eunsin Ha; Jin Young Park; Naoya Sakamoto; Jaehun Cheong
Journal:  FEBS Lett       Date:  2009-07-23       Impact factor: 4.124

View more
  11 in total

1.  Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus.

Authors:  Donna N Douglas; Christopher Hao Pu; Jamie T Lewis; Rakesh Bhat; Anwar Anwar-Mohamed; Michael Logan; Garry Lund; William R Addison; Richard Lehner; Norman M Kneteman
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

Review 2.  Liver steatosis in hepatitis C patients.

Authors:  Emilio González-Reimers; Geraldine Quintero-Platt; Melchor Rodríguez-Gaspar; Remedios Alemán-Valls; Onán Pérez-Hernández; Francisco Santolaria-Fernández
Journal:  World J Hepatol       Date:  2015-06-08

3.  Carbohydrate deficient transferrin and alcoholism.

Authors:  Hilary Denis Solomons
Journal:  Germs       Date:  2012-06-01

4.  Function annotation of hepatic retinoid x receptor α based on genome-wide DNA binding and transcriptome profiling.

Authors:  Qi Zhan; Yaping Fang; Yuqi He; Hui-Xin Liu; Jianwen Fang; Yu-Jui Yvonne Wan
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

5.  PPARs in Liver Diseases and Cancer: Epigenetic Regulation by MicroRNAs.

Authors:  Marion Peyrou; Pierluigi Ramadori; Lucie Bourgoin; Michelangelo Foti
Journal:  PPAR Res       Date:  2012-09-13       Impact factor: 4.964

6.  Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases.

Authors:  Liang Wu; Qingchun Pan; Guangyu Wu; Lingling Qian; Jing Zhang; Lei Zhang; Qichen Fang; Guoqing Zang; Yudong Wang; George Lau; Huating Li; Weiping Jia
Journal:  Sci Rep       Date:  2017-11-28       Impact factor: 4.379

7.  Plasticizers May Activate Human Hepatic Peroxisome Proliferator-Activated Receptor α Less Than That of a Mouse but May Activate Constitutive Androstane Receptor in Liver.

Authors:  Yuki Ito; Toshiki Nakamura; Yukie Yanagiba; Doni Hikmat Ramdhan; Nozomi Yamagishi; Hisao Naito; Michihiro Kamijima; Frank J Gonzalez; Tamie Nakajima
Journal:  PPAR Res       Date:  2012-06-20       Impact factor: 4.964

8.  Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity.

Authors:  Nathan J Shores; Maria Cássia Mendes-Corrêa; Ivana Maida; JoLyn Turner; Kevin P High; Sergio Babudieri; Marina Núãez
Journal:  Clinics (Sao Paulo)       Date:  2015-12       Impact factor: 2.365

9.  Lymphocytes as liver damage mirror of HCV related adipogenesis deregulation.

Authors:  Antonella Minutolo; Beatrice Conti; Sandro Grelli; Carmela Viscomi; Giancarlo Labbadia; Clara Balsano
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

10.  Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways.

Authors:  Kyong Joo Lee; Yoon Ok Jang; Seung-Kuy Cha; Moon Young Kim; Kyu-Sang Park; Young Woo Eom; Soon Koo Baik
Journal:  Gut Liver       Date:  2018-07-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.